Navigation Links
Prostate Brachytherapy Causes Fewer Side Effects Than Surgery

Men with prostate cancer have a slightly better long-term side effects profile with radiation seed implants than they do with surgery, according to a study.//

Doctors in France conducted the first-ever multi-institutional, comparative study of men with early stage prostate cancer to evaluate a man’s quality of life, treatment-related side effects and cost of the treatment based on the type of treatment the patient received: surgery or seed implants, both widely-accepted modes of treatment for early-stage prostate cancer. With prostate surgery, called a radical prostatectomy, a surgeon removes the prostate. During prostate brachytherapy, a radiation oncologist places radioactive seeds, similar to the size of a grain of rice, into the prostate to kill the cancer.

In this study, 435 men with prostate cancer were surveyed before treatment, immediately after treatment and subsequently at follow-up exams to gauge their quality of life and treatment-related side effects against predefined materials given to them by the doctors. Doctors found that brachytherapy is a more expensive procedure at the outset, but that follow-up costs related to surgery cause both treatments to cost about the same.

With regard to side effects, surgery had more significant side effects immediately following treatment, but those side effects improved steadily over two years. Brachytherapy, however, showed moderate, but persistent side effects over the two years. Urinary incontinence was more common after surgery; however, urinary irritation was a more common complaint from those who received brachytherapy. Impairment of sexual function was found to be consistently higher among those who received surgery than those who received brachytherapy.

“This study is exciting because it’s the first time we have a comparative study to assess the costs in a given country and see if the side effects are different for patients who received surgery or brachytherapy ,” said Jean-Marc Cosset, M.D., one of the authors of the study and a radiation oncologist in the Department of Radiation Oncology at the Institut Curie in Paris, France. “By looking at these factors, we are better able to tailor a suitable treatment option for the individual patient.”

Source-Bio-Bio TechnologySRM
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/5/2016)... ... May 05, 2016 , ... A local ... that more than 40 percent of participating fifth-grade students already have or are ... and Asthma Clinical Research in the Division of Pulmonary, Allergy and Critical Care ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... , ... May 05, 2016 , ... The 2016 Nike ... Derek Pittman, along with his university coaching staff. Together they bring their winning Vandals ... sessions run for youth players ages 5-13, and high school players. Session dates are ...
(Date:5/5/2016)... ... May 05, 2016 , ... When stiff and achy ... alleviate the pain that’s a common osteoarthritis (OA) symptom. Yet, numerous clinical studies ... with arthritis. , “Physical therapy exercises are commonly prescribed to individuals with ...
(Date:5/5/2016)... ... May 05, 2016 , ... The Lung Institute will celebrate its three-year ... seminar at most clinic locations throughout the month of May. To date, the Lung Institute ... rapid growth that we’ve seen is a testament to the success of this treatment and ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 Yissum Research Development ... today that it had signed an exclusive world-wide licensing ... of novel protein degradation and immunomodulatory drugs for cancer ... drug candidates representing first-in-class therapy for hematologic and solid ... The novel technology was developed by ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Acute Myeloid Leukemia ...  report to their offering.       ... Acute Myeloid Leukemia Market and Competitive Landscape ... Myeloid Leukemia pipeline products, Acute Myeloid Leukemia ...
(Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
Breaking Medicine Technology: